Status:
COMPLETED
Biomarkers and Preeclampsia Outcomes
Lead Sponsor:
Dacima Consulting
Collaborating Sponsors:
Maternity Center of Tunis
Conditions:
Preeclampsia
Eligibility:
FEMALE
20-50 years
Brief Summary
Prospective, observational, monocentric, non-interventional study.
Detailed Description
In practice, patients with preeclampsia are referred to the hospital for medical management only clinical signs \& symptoms and standard biological tests are available for patient individualized care....
Eligibility Criteria
Inclusion
- Suspected or confirmed preeclampsia
- Singleton pregnancy
- Between 26 weeks of gestation and 37 weeks of gestation \& 6 days
Exclusion
- Multiple pregnancies
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2022
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT03801447
Start Date
April 1 2018
End Date
June 30 2022
Last Update
August 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maternity Center of Tunis
Tunis, Tunisia, 1006